Alerts will be sent to your verified email
Verify EmailDLCL
|
Dr Lalchandani Labs
|
Clinitech Laboratory
|
Dolphin Medical Serv
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
6.03 % | 19.47 % | 0.0 |
|
5yr average Equity Multiplier
|
1.69 | 1.81 | 1.64 |
|
5yr Average Asset Turnover Ratio
|
0.43 | 1.31 | 0.06 |
|
5yr Avg Net Profit Margin
|
1.96 % | 7.42 % | -93.86 % |
|
Price to Book
|
0.0 | 0.0 | 0.99 |
|
P/E
|
20.7 | 22.26 | 245.55 |
|
5yr Avg Cash Conversion Cycle
|
103.23 Days | -48.54 Days | -0.39 Days |
|
Inventory Days
|
78.71 Days | 10.56 Days | 10.67 Days |
|
Days Receivable
|
408.23 Days | 47.42 Days | 0.0 |
|
Days Payable
|
262.63 Days | 133.84 Days | 3.27 Days |
|
5yr Average Interest Coverage Ratio
|
3.16 | 10.37 | -5.67 |
|
5yr Avg ROCE
|
5.08 % | 22.56 % | -2.53 % |
|
5yr Avg Operating Profit Margin
|
14.13 % | 16.43 % | -6.43 % |
|
5 yr average Debt to Equity
|
0.48 | 0.31 | 0.59 |
|
5yr CAGR Net Profit
|
-16.1 % | -0.51 % | -49.28 % |
|
5yr Average Return on Assets
|
1.95 % | 10.1 % | -4.25 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
32.9 % | 64.2 % | 26.44 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-27.88 % | 2.62 % | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Dr Lalchandani Labs
|
Clinitech Laboratory
|
Dolphin Medical Serv
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|